The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 90 (high attention) · dilution pressure high · listing risk elevated · governance risk elevated · runway 1.2 mo · strongest signal: Equity line (Aug 4, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going concern in 8-k, runway < 6 months) coexists with live selling machinery (atm program, equity line, pipe, shelf filed). Base case is a discounted raise; the question is when, not if.
Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.
A fresh shelf is on file with under a year of cash — the ingredients of an offering before the next 10-K. First shelf registration in 12 months filed with ~1.2 months of runway. Companies rarely file a shelf they do not intend to use.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 14, 2026 | ▼ Shelf filed | S-3 filed 2026-08-14 filing | 39 |
| Aug 14, 2026 | ▼ ATM program | “atm” language in S-3 (S-3) filed 2026-08-14 filing | 34 |
| Aug 14, 2026 | ▼ Going-concern language | “going concern periodic” language in 10-Q (10-Q) filed 2026-08-14 filing | 18 |
| Aug 6, 2026 | ▼ Reverse split | “reverse split” language in 8-K (8-K) filed 2026-08-06 filing | 32 |
| Aug 4, 2026 | ▼ Equity line | “equity line” language in 8-K (EX-10.1) filed 2026-08-04 filing | 51 |
| Aug 4, 2026 | ▼ ATM program | “atm” language in 8-K (EX-99.1) filed 2026-08-04 filing | 41 |
| Aug 4, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-08-04 (accepted 16:44 ET) filing | 41 |
| Aug 4, 2026 | ▼ PIPE | “pipe” language in 8-K (8-K) filed 2026-08-04 filing | 33 |
| Aug 4, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-10.3) filed 2026-08-04 filing | 32 |
| Aug 4, 2026 | ▼ Going concern in 8-K | “going concern 8k” language in 8-K (EX-99.1) filed 2026-08-04 filing | 31 |
| Jul 20, 2026 | ▼ Going concern in 8-K | “going concern 8k” language in 8-K (EX-99.1) filed 2026-07-20 filing | 31 |
| Jun 30, 2026 | ▼ Runway < 6 months | ~1.2 months runway: liquidity $1,022,606 as of 2026-06-30, burn $10,084,707/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 48 |
| Jun 30, 2026 | ▼ Share count +25% | Shares outstanding 2,659,288 (2026-05-15) -> 3,516,988 (2026-08-14), +32% filing | 34 |
| Jun 30, 2026 | ▼ Near $5M MVLS floor | Public float $3,340,000 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing | 28 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →